Skip to content
2000
Volume 15, Issue 11
  • ISSN: 1389-2010
  • E-ISSN: 1873-4316

Abstract

Oridonin, an ent-kaurane diterpenoid mainly extracted from Chinese medical plant Rabdosia rubescens and some related species, has been reported its remarkable antitumor efficacy in various cancer cells. This review will be focused on the underlying molecular mechanisms for the treatments of oridonin in hematological malignancies, which include the regulation of oncoproteins (AML1-ETO, NPM1 mutants, PML-RARα, ABL kinase), accumulation of ROS, modulation of MAPKs and PI3K/Akt signaling pathways, and changes of abnormal expressions of MicroRNAs. And we get the conclusion that oridonin is a promising natural product with multiple targets against hematological malignancies.

Loading

Article metrics loading...

/content/journals/cpb/10.2174/1389201015666141111115608
2014-11-01
2025-07-11
Loading full text...

Full text loading...

/content/journals/cpb/10.2174/1389201015666141111115608
Loading

  • Article Type:
    Research Article
Keyword(s): antitumor; hematological malignancies; molecular mechanism; Oridonin
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test